Shared Decision-Making in Diabetes Care

Current Diabetes Reports

Volumn 15, Issue 12, 2015, Pages

  Tamhane, Shrikant ^a   Rodriguez Gutierrez, Rene ^a   Hargraves, Ian ^a   Montori, Victor M ^a  

^a MAYO CLINIC   (United States)

Author keywords

Decision aids; Diabetes; Evidence based medicine; Shared decision making

Indexed keywords

CLINICAL DECISION MAKING; CLINICAL PRACTICE; COOPERATION; DIABETES CONTROL; DIABETES MELLITUS; EVIDENCE BASED MEDICINE; FEASIBILITY STUDY; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; PATIENT CARE; PATIENT DECISION MAKING; PATIENT PREFERENCE; PUBLIC HEALTH PROBLEM; REVIEW; SHARED DECISION MAKING; TRANSLATIONAL RESEARCH; TREATMENT INDICATION; DECISION MAKING;

DECISION MAKING; DIABETES MELLITUS; EVIDENCE-BASED MEDICINE; HUMANS;

EID: 84944057894     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-015-0688-0     Document Type: Review

References (72)

1. Barry MJ, Edgman-Levitan S. Shared decision making—pinnacle of patient-centered care. N Engl J Med. 2012;366(9):780–1. This article patly describes the important concept of recognition of shared decision making as the pinnacle of patient-centered care.
2. Djulbegovic B, Guyatt GH. Evidence-based practice is not synonymous with delivery of uniform health care. JAMA. 2014;312(13):1293–4.
3. Stiggelbout AM, Van der Weijden T, De Wit MP, et al. Shared decision making: really putting patients at the centre of healthcare. BMJ. 2012;344:e256. This article describes the perceprtion and realty of use of SDM by clinicians and highlight some best practices.
4. Elwyn G, Lloyd A, May C, et al. Collaborative deliberation: a model for patient care. Patient Educ Couns. 2014;97(2):158–64.
5. Saulsberry WJ, Coleman CI, Mearns ES, et al. Comparative efficacy and safety of antidiabetic drug regimens added to stable and inadequate metformin and thiazolidinedione therapy in type 2 diabetes. Int J Clin Pract. 2015;198:87–8.
6. Mearns ES, Saulsberry WJ, White CM, et al. Efficacy and safety of antihyperglycaemic drug regimens added to metformin and sulphonylurea therapy in type 2 diabetes: a network meta-analysis. Diabet Med. 2015.
7. Monami M, Lamanna C, Marchionni N, et al. Comparison of different drugs as add-on treatments to metformin in type 2 diabetes: a meta-analysis. Diabetes Res Clin Pract. 2008;79(2):196–203.
8. Phung OJ, Scholle JM, Talwar M, et al. Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes. JAMA. 2010;303(14):1410–8.
9. Montori VM, Guyatt GH. Progress in evidence-based medicine. JAMA. 2008;300(15):1814–6.
10. Crawley L. Evidence-based medicine: a new paradigm for the patient. JAMA. 1993;269(10):1253. author reply 4.
11. Davidoff F, Haynes B, Sackett D, et al. Evidence based medicine. BMJ. 1995;310(6987):1085–6.
12. Sackett DL, Rosenberg WM, Gray JA, et al. Evidence based medicine: what it is and what it isn't. BMJ. 1996;312(7023):71–2.
13. Richardson PE. David Sackett and the birth of evidence based medicine: how to practice and teach EBM. BMJ. 2015;350:h3089.
14. Hoffmann TC, Montori VM, Del Mar C. The connection between evidence-based medicine and shared decision making. JAMA. 2014;312(13):1295–6. This article provides an improtant concept of the interdependence of EBM and Shared Decision Making.
15. Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med. 1999;49(5):651–61.
16. Montori VM, Gafni A, Charles C. A shared treatment decision-making approach between patients with chronic conditions and their clinicians: the case of diabetes. Health Expect. 2006;9(1):25–36.
17. Elwyn G, Frosch D, Volandes AE, et al. Investing in deliberation: a definition and classification of decision support interventions for people facing difficult health decisions. Med Decis Making. 2010;30(6):701–11.
18. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21(9):1414–31.
19. van Dieren S, Beulens JW, van der Schouw YT, et al. The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil. 2010;17 Suppl 1:S3–8.
20. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med. 1997;14 Suppl 5:S1–85.
21. Seuring T, Archangelidi O, Suhrcke M. The economic costs of type 2 diabetes: a global systematic review. Pharmacoeconomics. 2015;18(2):141–2.
22. Muka T, Imo D, Jaspers L, et al. The global impact of non-communicable diseases on healthcare spending and national income: a systematic review. Eur J Epidemiol. 2015;30(4):251–77.
23. Kankeu HT, Saksena P, Xu K, et al. The financial burden from non-communicable diseases in low- and middle-income countries: a literature review. Health Res Policy Syst. 2013;11:31.
24. Naykky Singh-Ospina1* RR-G, Juan P. Brito1. Is the endocrine research pipeline broken?—a systematic evaluation of the Endocrine Society clinical practice guidelines and trial registration.
25. Kahn SE, Haffner SM, Heise MA, et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med. 2006;355(23):2427–43.
26. Bennett WL, Odelola OA, Wilson LM, et al. Evaluation of guideline recommendations on oral medications for type 2 diabetes mellitus: a systematic review. Ann Intern Med. 2012;156(1 Pt 1):27–36.
27. Bennett WL, Maruthur NM, Singh S, et al. Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann Intern Med. 2011;154(9):602–13.
28. International Diabetes Federation. Global guideline for type 2 diabetes. 2012. http://www.idf.org/global-guideline-type-2-diabetes-2012 Accessed 2015 Sept 10.
29. Guidelines ADA/EASD 2015. http://www.ndei.org/ADA-EASD-guidelines-hyperglycemia-management-type-2-diabetes-treatment-algorithm-.aspx. Accessed 2015 Sept 10.
30. Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32(1):193–203.
31. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38(1):140–9.
32. Magnan EM, Palta M, Mahoney JE, et al. The relationship of individual comorbid chronic conditions to diabetes care quality. BMJ Open Diabetes Res Care. 2015;3(1):e000080.
33. Fortin M, Soubhi H, Hudon C, et al. Multimorbidity’s many challenges. BMJ. 2007;334(7602):1016–7.
34. Eton DT, Ridgeway JL, Egginton JS, et al. Finalizing a measurement framework for the burden of treatment in complex patients with chronic conditions. Patient Relat Outcome Meas. 2015;6:117–26.
35. Montori VM, Breslin M, Maleska M, et al. Creating a conversation: insights from the development of a decision aid. PLoS Med. 2007;4(8):e233.
36. Agoritsas T, Heen AF, Brandt L, et al. Decision aids that really promote shared decision making: the pace quickens. BMJ. 2015;350:g7624.
37. Montori VM, LeBlanc A, Buchholz A, et al. Basing information on comprehensive, critically appraised, and up-to-date syntheses of the scientific evidence: a quality dimension of the International Patient Decision Aid Standards. BMC Med Inform Decis Mak. 2013;13 Suppl 2:S5.
38. Stacey D, Legare F, Col NF, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2014;1:CD001431.
39. Mullan RJ, Montori VM, Shah ND, et al. The diabetes mellitus medication choice decision aid_ a randomized trial. Arch Intern Med. 2009;169(17):1560–8.
40. Weymiller AJ, Montori VM, Jones LA, et al. Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial. Arch Intern Med. 2007;167(10):1076–82.
41. Mann DM, Ponieman D, Montori VM, et al. The Statin Choice decision aid in primary care: a randomized trial. Patient Educ Couns. 2010;80(1):138–40.
42. Mathers N, Ng CJ, Campbell MJ, et al. Clinical effectiveness of a patient decision aid to improve decision quality and glycaemic control in people with diabetes making treatment choices: a cluster randomised controlled trial (PANDAs) in general practice. BMJ Open. 2012;2(6):e001469.
43. Branda ME, LeBlanc A, Shah ND, et al. Shared decision making for patients with type 2 diabetes: a randomized trial in primary care. BMC Health Serv Res. 2013;13:301.
44. Diabetes Decision Aid. Mayo Clinic. http://diabetesdecisionaid.mayoclinic.org/. Accessed 2015 Sept 10.
45. Statin Decision Aid. Mayo Clinic. http://statindecisionaid.mayoclinic.org/. Accessed 2015 Sept 10.
46. Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, et al. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ. 2011;343:d4169.
47. Hemmingsen B, Lund SS, Gluud C, et al. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2013;11:CD008143.
48. Standards of medical care in diabetes—2014. Diabetes Care. 2014;37(Suppl 1):S14–80.
49. Qaseem A, Vijan S, Snow V, et al. Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin A1c targets. A guidance statement from the American College of Physicians. Ann Intern Med. 2007;147(6):417–22.
50. Horvath K, Jeitler K, Berghold A, et al. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2007;2:CD005613.
51. Singh SR, Ahmad F, Lal A, et al. Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis. CMAJ. 2009;180(4):385–97.
52. Hargraves I, Montori VM. Decision aids, empowerment, and shared decision making. BMJ. 2014;349:g5811.
53. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 2010;303(20):2043–50.
54. Glasgow RE, Klesges LM, Dzewaltowski DA, et al. The future of health behavior change research: what is needed to improve translation of research into health promotion practice? Ann Behav Med. 2004;27(1):3–12.
55. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348(26):2635–45.
56. Elwyn G, Laitner S, Coulter A, et al. Implementing shared decision making in the NHS. BMJ. 2010;341:c5146.
57. Holmes-Rovner M, Valade D, Orlowski C, et al. Implementing shared decision-making in routine practice: barriers and opportunities. Health Expect. 2000;3(3):182–91.
58. Agency for Healthcare Research and Quality. U.S. Department of Health & Human Services. https://cahps.ahrq.gov/quality-improvement/improvement-guide/browse-interventions/Communication/Shared-Decision-Making/index.html. Accessed 2015 Sept 10.
59. Institute of Clinical Systems Improvement. https://www.icsi.org/health_initiatives/shared_decision-making/. Accessed 2015 Sept 10.
60. Patient-Centered Outcomes Research Institute (PCORI). http://www.pcori.org/. Accessed 2015 Sept 10.
61. American Diabetes Association (ADA). http://professional.diabetes.org/ResourcesForProfessionals.aspx?cid=84160. Accessed 2015 Sept 10.
62. Knowledge evaluation and research unit at Mayo Clinic. http://shareddecisions.mayoclinic.org/. Accessed 2015 Sept 10.
63. American College of Cardiology (ACC). http://www.acc.org/. Accessed 2015 Sept 10.
64. Institute of Healthcare Improvement (IHI). http://www.ihi.org/education/IHIOpenSchool/resources/Pages/Activities/VictorMontoriSharedDecisionMaking.aspx. Accessed 2015 Sept 10.
65. National Health Service. http://sdm.rightcare.nhs.uk/. Accessed 2015 Sept 10.
66. Legare F, Ratte S, Gravel K, et al. Barriers and facilitators to implementing shared decision-making in clinical practice: update of a systematic review of health professionals’ perceptions. Patient Educ Couns. 2008;73(3):526–35.
67. Lee CN, Hultman CS, Sepucha K. Do patients and providers agree about the most important facts and goals for breast reconstruction decisions? Ann Plast Surg. 2010;64(5):563–6.
68. Mulley AG, Trimble C, Elwyn G. Stop the silent misdiagnosis: patients’ preferences matter. BMJ. 2012;345:e6572.
69. Street Jr RL, Haidet P. How well do doctors know their patients? Factors affecting physician understanding of patients’ health beliefs. J Gen Intern Med. 2011;26(1):21–7.
70. Legare F, Stacey D, Turcotte S. Interventions for improving the adoption of shared decision making by healthcare professionals. Cochrane Database Syst Rev. 2014;9:CD006732.
71. Option Grid Collaborative. http://optiongrid.org/option-grids/current-grids. Accessed 2015 Sept 10.
72. Elwyn G, O'Connor AM, Bennett C, et al. Assessing the quality of decision support technologies using the International Patient Decision Aid Standards instrument (IPDASi). PLoS One. 2009;4(3):e4705.